The goal of Remedy’s communication is to ensure that all participants in the market have – simultaneously and without delay – sufficient, reliable, essential and consistent information about the company and its operations as well as about matters affecting the value of the company’s financial instrument.
Information that may affect the value of the company’s financial instrument will be announced to the capital markets and other key stakeholders simultaneously and without undue delay.
The Communications and Disclosure Policy is approved and confirmed by the Board of Directors.
All company announcements and press releases are published on the company’s website. The company’s official communications language is Finnish, although majority of the material is available in English as well.
Disclosure of financial data and financial targets
Remedy publishes business reviews, half-year reviews and full-year financial statements releases according to the published annual schedule.
Remedy may tell about its future prospects annually in the annual report of the Board. In addition, the company assesses its future development in the published financial reports. The company does not publish profit forecasts.
A silent period always precedes the regularly published financial reports, which begins 30 days prior to the publication date of the following financial report and ends upon the publication of the financial report.
During the silent period, Remedy does not comment on the company’s financial situation, markets or future prospects. Additionally during the silent period, the company representatives do not meet investors, analysts or other market operators or give interviews or otherwise comment on matters concerning the company’s financial situation or general views.
The Chairman of the Board or the Chief Executive Director shall on a case-by-case basis decide on whether to give interviews on inside information published during the silent period.
Remedy observes a closed period of 30 days prior to the publication of business reviews, half-year reviews and financial statements releases.
During the closed period, the company’s managers with an obligation to disclose, and legally incompetent persons under the custody or trusteeship of such managers, as well as any organizations in which the above-mentioned persons exercise significant influence or control, may not trade in the company’s financial instruments on their own account or the account of a third party.
The trading prohibition during the closed window also applies to personnel who participate in the preparation and publication of financial reports. The closed window ends upon the publication of a financial report.